Amphastar Pharmaceuticals Free Cash Flow 2012-2023 | AMPH
Amphastar Pharmaceuticals free cash flow from 2012 to 2023. Free cash flow can be defined as a measure of financial performance calculated as operating cash flow minus capital expenditures.
| Amphastar Pharmaceuticals Annual Free Cash Flow |
| 2023 |
145.34 |
| 2022 |
65.57 |
| 2021 |
70.54 |
| 2020 |
23.41 |
| 2019 |
0.21 |
| 2018 |
-8.37 |
| 2017 |
4.11 |
| 2016 |
17.18 |
| 2015 |
-5.32 |
| 2014 |
0.55 |
| 2013 |
12.74 |
| 2012 |
-25.31 |
| 2011 |
8.42 |
| 2009 |
|
| Amphastar Pharmaceuticals Quarterly Free Cash Flow |
| 2023-12-31 |
145.34 |
| 2023-09-30 |
130.92 |
| 2023-06-30 |
76.77 |
| 2023-03-31 |
30.91 |
| 2022-12-31 |
65.57 |
| 2022-09-30 |
56.65 |
| 2022-06-30 |
41.90 |
| 2022-03-31 |
44.63 |
| 2021-12-31 |
70.54 |
| 2021-09-30 |
36.98 |
| 2021-06-30 |
41.63 |
| 2021-03-31 |
15.21 |
| 2020-12-31 |
23.41 |
| 2020-09-30 |
15.85 |
| 2020-06-30 |
12.11 |
| 2020-03-31 |
-6.74 |
| 2019-12-31 |
0.21 |
| 2019-09-30 |
2.97 |
| 2019-06-30 |
23.65 |
| 2019-03-31 |
-18.35 |
| 2018-12-31 |
-8.37 |
| 2018-09-30 |
-8.55 |
| 2018-06-30 |
-11.70 |
| 2018-03-31 |
-3.98 |
| 2017-12-31 |
4.11 |
| 2017-09-30 |
4.46 |
| 2017-06-30 |
13.40 |
| 2017-03-31 |
15.13 |
| 2016-12-31 |
17.18 |
| 2016-09-30 |
8.51 |
| 2016-06-30 |
10.70 |
| 2016-03-31 |
9.98 |
| 2015-12-31 |
-5.32 |
| 2015-09-30 |
-4.48 |
| 2015-06-30 |
-3.74 |
| 2015-03-31 |
-2.84 |
| 2014-12-31 |
0.55 |
| 2014-09-30 |
-2.94 |
| 2014-06-30 |
-12.36 |
| 2014-03-31 |
-10.06 |
| 2013-12-31 |
12.74 |
| 2013-09-30 |
8.13 |
| 2013-06-30 |
11.95 |
| 2013-03-31 |
-4.92 |
| 2012-12-31 |
-25.31 |
| 2012-09-30 |
|
| 2012-06-30 |
|
| 2012-03-31 |
|
| 2011-12-31 |
|
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Generic Drugs |
$1.957B |
$0.644B |
|
Amphastar Pharmaceuticals, Inc. is a specialty pharmaceutical company. It focuses primarily on developing, manufacturing, marketing, and selling generic and proprietary injectable and inhalation products. The company products include Enoxaparin Sodium Injection; Amphadase; Cortrosyn for Injection; and prefilled disposable emergency syringes for crash cart use. Amphastar Pharmaceuticals, Inc. is headquartered in Rancho Cucamonga, California.
|
